Who owns Y Mabs Therapeutics Inc?
- Ticker: YMAB
- CUSIP Number: 984241109
Tip: Access positions for across all investors
Analyze quarterly positions in Y Mabs Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Y Mabs Therapeutics stock
Who bought or sold Y Mabs Therapeutics Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
---|---|---|---|---|---|---|
Wellington Management Company | 4.3M | $69M | 0% | Dec 2021 | ||
Alliancebernstein | 3.0M | $35M | 109% | Mar 2022 | ||
FMR | 2.0M | $23M | 29% | Mar 2022 | ||
Vanguard Group | 1.8M | $21M | -1% | Mar 2022 | ||
Geode Capital Management | 584k | $6.9M | -6% | Mar 2022 | ||
Morgan Stanley | 542k | $6.4M | 100% | Mar 2022 | ||
MPM Oncology Impact Management | 444k | $5.3M | -1% | Mar 2022 | ||
Artal Group | 400k | $6.5M | 0% | Dec 2021 | ||
Lombard Odier Asset Management | 385k | $6.2M | 9% | Dec 2021 | ||
Northern Trust | 327k | $3.9M | -5% | Mar 2022 | ||
Deutsche Bank Aktiengesellschaft | 305k | $3.7M | 1150% | Mar 2022 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Y Mabs Therapeutics? |
||||||
Logos Global Management | 250k | $4.1M | 100% | Dec 2021 | ||
Soleus Capital Management | 239k | $2.8M | -10% | Mar 2022 | ||
Charles Schwab Investment Management | 234k | $2.8M | -4% | Mar 2022 | ||
Ashford Capital Management | 226k | $3.7M | -50% | Dec 2021 | ||
Citadel Advisors | 207k | $2.5M | 65% | Mar 2022 | ||
Memorial Sloan Kettering Cancer Center | 191k | $2.3M | -12% | Mar 2022 | ||
Dimensional Fund Advisors | 183k | $2.2M | -4% | Mar 2022 | ||
Candriam Luxembourg S.C.A. | 173k | $0 | -6% | Mar 2022 | ||
Cormorant Asset Management | 150k | $1.8M | -70% | Mar 2022 | ||
Rafferty Asset Management | 140k | $1.7M | 100% | Mar 2022 | ||
D. E. Shaw & Co | 139k | $1.6M | 100% | Mar 2022 | ||
Goldman Sachs Group | 126k | $1.5M | -42% | Mar 2022 | ||
Nuveen Asset Management | 107k | $1.3M | -24% | Mar 2022 | ||
Bank of New York Mellon | 104k | $1.2M | 1% | Mar 2022 | ||
State of Wisconsin Investment Board | 92k | $1.1M | 125% | Mar 2022 | ||
Renaissance Technologies | 91k | $1.1M | -8% | Mar 2022 | ||
Rice Hall James & Associates | 90k | $1.1M | 7% | Mar 2022 | ||
Bank of America Corporation | 82k | $1.3M | 100% | Dec 2021 | ||
Citigroup | 68k | $1.1M | 100% | Dec 2021 | ||
Swiss National Bank | 62k | $737k | 8% | Mar 2022 | ||
Barclays | 60k | $973k | 243% | Dec 2021 | ||
ALPS Advisors | 51k | $819k | -5% | Dec 2021 | ||
Jpmorgan Chase & Co | 42k | $503k | 13% | Mar 2022 | ||
California State Teachers Retirement System | 37k | $443k | -9% | Mar 2022 | ||
Rhumbline Advisers | 36k | $590k | -2% | Dec 2021 | ||
Wells Fargo & Company | 29k | $852k | -31% | Dec 2021 | ||
Allianz Asset Management | 29k | $341k | -3% | Mar 2022 | ||
Teachers Retirement System Of The State Of Kentucky | 26k | $416k | 0% | Dec 2021 | ||
CNA Financial Corporation | 26k | $302k | 40% | Mar 2022 | ||
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 25k | $298k | 100% | Mar 2022 | ||
New York State Common Retirement Fund | 25k | $292k | -90% | Mar 2022 | ||
Brandywine Global Investment Management | 24k | $290k | 0% | Mar 2022 | ||
Virtus ETF Advisers | 24k | $383k | 88% | Dec 2021 | ||
Ergoteles | 23k | $274k | 100% | Mar 2022 | ||
MetLife Investment Advisors | 21k | $246k | 54% | Mar 2022 | ||
Credit Suisse | 19k | $226k | 14% | Mar 2022 | ||
Allspring Global Investments Holdings | 18k | $216k | 21% | Mar 2022 | ||
American International | 17k | $206k | -7% | Mar 2022 | ||
Manufacturers Life Insurance Company | 15k | $182k | -20% | Mar 2022 | ||
DekaBank Deutsche Girozentrale | 14k | $172k | 10% | Mar 2022 | ||
Cubist Systematic Strategies | 13k | $152k | 100% | Mar 2022 | ||
Florida State Board of Administration | 11k | $133k | 0% | Mar 2022 | ||
ProShare Advisors | 11k | $132k | -20% | Mar 2022 | ||
Ensign Peak Advisors | 4.3k | $70k | -28% | Dec 2021 | ||
Bnp Paribas Arbitrage, Snc | 2.9k | $35k | -68% | Mar 2022 | ||
Quantbot Technologies | 2.7k | $43k | 350% | Dec 2021 | ||
Summit Investment Advisors | 2.6k | $31k | 0% | Mar 2022 | ||
Metropolitan Life Insurance Company | 2.3k | $27k | -76% | Mar 2022 | ||
Zurcher Kantonalbank | 1.9k | $22k | 0% | Mar 2022 | ||
NISA Investment Advisors | 1.7k | $20k | 100% | Mar 2022 | ||
Great-West Life Assurance Company | 1.4k | $18k | 0% | Mar 2022 | ||
Cutler | 1.2k | $2.0k | 100% | Mar 2022 | ||
HighMark Wealth Management | 720.00 | $9.0k | -17% | Mar 2022 | ||
Lindbrook Capital | 674.00 | $8.0k | 1222% | Mar 2022 | ||
Cassady Schiller Wealth Management | 525.00 | $9.0k | 100% | Dec 2021 | ||
Macquarie Group | 471.00 | $6.0k | 0% | Mar 2022 | ||
Simplex Trading | 300.00 | $3.0k | 100% | Mar 2022 | ||
Signature | 244.00 | $3.0k | 194% | Mar 2022 | ||
Captrust Financial Advisors | 154.00 | $2.0k | 100% | Mar 2022 | ||
Daiwa Securities Group | 149.00 | $2.0k | 0% | Mar 2022 |
Who sold out of Y Mabs Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Artisan Partners Limited Partnership | Dec 2021 | 1.6M | $26M |
Russell Investments | Dec 2021 | 64k | $1.0M |
Jane Street | Dec 2021 | 45k | $724k |
Sei Investments | Sep 2021 | 25k | $716k |
ExodusPoint Capital Management | Sep 2021 | 17k | $497k |
Walleye Trading Advisors | Dec 2021 | 17k | $279k |
Qube Research & Technologies | Dec 2021 | 16k | $253k |
SG Americas Securities | Dec 2021 | 15k | $243k |
DnB NOR Asset Management AS | Dec 2021 | 13k | $217k |
Parametric Portfolio Associates | Sep 2021 | 11k | $315k |
The Allstate Corporation | Sep 2021 | 9.4k | $268k |
Arizona State Retirement System | Sep 2021 | 7.1k | $203k |
Advisor Group Holdings | Dec 2021 | 4.2k | $67k |
Us Bancorp | Dec 2021 | 1.3k | $21k |
Migdal Insurance & Financial Holdings | Dec 2021 | 730.00 | $12k |
TCI Wealth Advisors | Dec 2021 | 249.00 | $4.0k |